HCPs are unwanted impurities requiring removal during manufacturing, but new trehalose technology significantly reduces HCPs ...

Dublin, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Process Analytical Technology Market - Global Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering.

Antique expects the Concord to report revenue, Ebitda and PAT CAGR of 18 per cent, 17 per cent and 19 per cent, respectively, ...

Transcenta Therapeutics, a global biopharmaceutical company with capabilities in discovery, research, development and ...

FUJIFILM Corporation today announced the completion of one of Japan’s largest bio CDMO*1 facilities (the new plant) at the ...

An announcement from Xuanzhu Biopharmaceutical Co., Ltd. Class H ( ($HK:2575) ) is now available. Xuanzhu Biopharmaceutical has appointed its ...

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, confirms the planned announcement of the results from cohort 4 of the randomized, blinded, placebo-controlled ...

Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs present new challenges.

The DMTA cycle depends on clear data flow, yet most labs still work across disconnected systems. Sean McGee, Director of ...

Chitose Laboratory Corp., (CHITOSE), a leading company of the bioeconomy and provider of advanced cell line development services, and FUJIFILM Biosciences Inc., a global leader in the innovation and ...

Pfizer Inc (NYSE:PFE) maintains global operations across medicines and vaccines, delivering consistent earnings, operational ...